BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28777889)

  • 1. Determination of GnRH and its synthetic analogues' abuse in doping control: Small bioactive peptide UPLC-MS/MS method extension by addition of in vitro and in vivo metabolism data; evaluation of LH and steroid profile parameter fluctuations as suitable biomarkers.
    Zvereva I; Dudko G; Dikunets M
    Drug Test Anal; 2018 Apr; 10(4):711-722. PubMed ID: 28777889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS.
    Thomas A; Geyer H; Kamber M; Schänzer W; Thevis M
    J Mass Spectrom; 2008 Jul; 43(7):908-15. PubMed ID: 18563864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of gonadotropin-releasing hormone metabolites in greyhound urine.
    Palmer D; Rademaker K; Martin I; Hessell J; Howitt R
    Drug Test Anal; 2017 Oct; 9(10):1499-1505. PubMed ID: 28087978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of bioactive peptides including gonadotrophin-releasing factors (GnRHs) in horse urine using ultra-high performance liquid chromatography-high resolution mass spectrometry (UHPLC/HRMS).
    Kwok KY; Choi TLS; Kwok WH; Lau MY; Leung EMK; Leung GNW; Wong JKY; Wan TSM; Adrian FF; Prabhu A; Ho ENM
    Drug Test Anal; 2020 Sep; 12(9):1274-1286. PubMed ID: 32558326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of doping peptides via solid-phase microelution and accurate-mass quadrupole time-of-flight LC-MS.
    Cuervo D; Loli C; Fernández-Álvarez M; Muñoz G; Carreras D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Oct; 1065-1066():134-144. PubMed ID: 28939282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of IGF-1 and IGF-2, their degradation products and synthetic analogues in urine by LC-MS/MS.
    Thomas A; Kohler M; Schänzer W; Delahaut P; Thevis M
    Analyst; 2011 Mar; 136(5):1003-12. PubMed ID: 21157622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of markers out of the steroid profile for the screening of testosterone misuse. Part I: Transdermal administration.
    Kotronoulas A; Gomez-Gómez À; Fabregat A; Segura J; Yang S; Xing Y; Moutian W; Marcos J; Joglar J; Ventura R; Pozo OJ
    Drug Test Anal; 2018 May; 10(5):821-831. PubMed ID: 29148228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid-phase extraction of small biologically active peptides on cartridges and microelution 96-well plates from human urine.
    Semenistaya E; Zvereva I; Krotov G; Rodchenkov G
    Drug Test Anal; 2016 Sep; 8(9):940-9. PubMed ID: 26472487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal monitoring of endogenous steroids in human serum by UHPLC-MS/MS as a tool to detect testosterone abuse in sports.
    Ponzetto F; Mehl F; Boccard J; Baume N; Rudaz S; Saugy M; Nicoli R
    Anal Bioanal Chem; 2016 Jan; 408(3):705-19. PubMed ID: 26677027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin.
    Semenistaya E; Zvereva I; Thomas A; Thevis M; Krotov G; Rodchenkov G
    Drug Test Anal; 2015 Oct; 7(10):919-25. PubMed ID: 25869809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DMSO Assisted Electrospray Ionization for the Detection of Small Peptide Hormones in Urine by Dilute-and-Shoot-Liquid-Chromatography-High Resolution Mass Spectrometry.
    Judák P; Grainger J; Goebel C; Van Eenoo P; Deventer K
    J Am Soc Mass Spectrom; 2017 Aug; 28(8):1657-1665. PubMed ID: 28425052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring 2-phenylethanamine and 2-(3-hydroxyphenyl)acetamide sulfate in doping controls.
    Sigmund G; Dib J; Tretzel L; Piper T; Bosse C; Schänzer W; Thevis M
    Drug Test Anal; 2015; 7(11-12):1057-62. PubMed ID: 26481102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis by liquid chromatography Q-Orbitrap mass spectrometry: Fast screening of peptides and organic molecules.
    Sardela VF; Martucci MEP; de Araújo ALD; Leal EC; Oliveira DS; Carneiro GRA; Deventer K; Van Eenoo P; Pereira HMG; Aquino Neto FR
    J Mass Spectrom; 2018 Jun; 53(6):476-503. PubMed ID: 29524299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doping control analysis of trimetazidine and characterization of major metabolites using mass spectrometric approaches.
    Sigmund G; Koch A; Orlovius AK; Guddat S; Thomas A; Schänzer W; Thevis M
    Drug Test Anal; 2014; 6(11-12):1197-205. PubMed ID: 24913825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-run UHPLC-MS/MS method for simultaneous quantification of endogenous steroids and their phase II metabolites in serum for anti-doping purposes.
    Ponzetto F; Parasiliti-Caprino M; Gesmundo I; Marinelli L; Nonnato A; Nicoli R; Kuuranne T; Mengozzi G; Ghigo E; Settanni F
    Talanta; 2023 Apr; 255():124218. PubMed ID: 36603442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simplifying and expanding analytical capabilities for various classes of doping agents by means of direct urine injection high performance liquid chromatography high resolution/high accuracy mass spectrometry.
    Görgens C; Guddat S; Thomas A; Wachsmuth P; Orlovius AK; Sigmund G; Thevis M; Schänzer W
    J Pharm Biomed Anal; 2016 Nov; 131():482-496. PubMed ID: 27693991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of LongR
    Thomas A; Walpurgis K; Delahaut P; Fichant E; Schänzer W; Thevis M
    Growth Horm IGF Res; 2017 Aug; 35():33-39. PubMed ID: 28668757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of two glucuronides resistant to enzymatic hydrolysis as markers of testosterone oral administration.
    Kotronoulas A; Gomez-Gomez A; Segura J; Ventura R; Joglar J; Pozo OJ
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):212-218. PubMed ID: 27328448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Stimulants and Narcotics by Liquid Chromatography-Tandem Mass Spectrometry and Gas Chromatography-Mass Spectrometry for Sports Doping Control.
    Ahrens BD; Kucherova Y; Butch AW
    Methods Mol Biol; 2016; 1383():247-63. PubMed ID: 26660193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.